Rasagiline is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Reference standards of Rasagiline API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
No Data Found